SCHEMBL25917

SCHEMBL25917

OC(C(F)F)C(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8210654 0.80
SCHEMBL17014691 0.74
SCHEMBL7027658 0.74
SCHEMBL564379 0.74
SCHEMBL29044777 0.74
SCHEMBL13057619 0.74
SCHEMBL5200469 0.74
SCHEMBL17473229 0.74
Hydrochloric Acid SCHEMBL29239228 0.71
SCHEMBL9853 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702021-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2026-03-04 EP disclosed
US-20250343048-A1 ETCHING METHOD RESONAC CORPORATION (JP) 2025-11-06 US disclosed
EP-4556084-A1 NOVEL UNSATURATED HYDROBROMOFLUOROCARBON FIRE SUPPRESSANTS Kidde Graviner Limited (GB) 2025-05-21 EP disclosed
US-20250154084-A1 NOVEL UNSATURATED HYDROBROMOFLUOROCARBON FIRE SUPPRESSANTS KIDDE GRAVINER LIMITED (GB) 2025-05-15 US disclosed
EP-4481794-A1 ETCHING METHOD Resonac Corporation (JP) 2024-12-25 EP disclosed
CN-119110820-A Process for producing fluoropolyether group-containing compound 大金工业株式会社 2024-12-10 CN disclosed
US-20240368173-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-11-07 US disclosed
WO-2024224064-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2024-10-31 WO disclosed
CN-118679554-A Etching method 株式会社力森诺科 2024-09-20 CN disclosed
EP-4419203-A1 TRICYCLIC GPR65 MODULATORS Pathios Therapeutics Limited (GB) 2024-08-28 EP disclosed
US-20050250761-A1 such as -Piperidin-1-yl-but-2-enoic acid [4(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yl]-amide, used as tyrosine kinase inhibitors, for the prevention of proliferative diseases, including cancer, atherosclerosis, restenosis, endometriosis and psoriasis PFIZER INC 2005-11-10 US disclosed
EP-1474144-A1 CONTROLLED RELEASE PHARMACEUTICAL DOSAGE FORMS OF A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR Pfizer Products Inc. (US) 2004-11-10 EP disclosed
WO-2003063868-A1 CONTROLLED RELEASE PHARMACEUTICAL DOSAGE FORMS OF A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR PFIZER PRODUCTS INC. (US) 2003-08-07 WO disclosed
US-6388160-B1 DIMERIZATION OF PROPLYLENE USING NICKEL COMPLEX CATALYST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-05-14 US disclosed
US-6110961-A USEFUL IN PROPHYLAXIS AND TREATMENT OF MENTAL DISORDERS, SUCH AS DEPRESSION, ANXIETY KRENITSKY PHARMACEUTICALS, INC. (US) 2000-08-29 US disclosed
EP-1021434-A2 PHARMACOLOGICALLY ACTIVE COMPOUNDS AND USE Krenitsky Pharmaceuticals, Inc. (US) 2000-07-26 EP disclosed
WO-1998012190-A2 PHENOXATHIIN DERIVATIVES AS INHIBITORS OF MONOAMINE OXIDASE KRENITSKY PHARMACEUTICAL, INC. (US) 1998-03-26 WO disclosed
EP-0231748-B1 PROCESS FOR DIMERIZING LOWER ALPHA-OLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-08-02 EP disclosed
US-4709112-A DIMERIZATION CATALYST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-11-24 US disclosed
US-3714271-A PRODUCTION OF POLYFLUOROPROPANOLS OMNIS SURGICAL INC., A DE CORP. 1973-01-30 US disclosed